KREBS BIOCHEMICALS & IND Financial Ratios
KREBSBIO · Healthcare · Current price ₹53.69
P/E ratio
—
P/B ratio
-0.8x
ROE
18.4%
ROCE
-30.0%
Debt / Equity
0.00
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | — | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | -0.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 18.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -30.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with KREBS BIOCHEMICALS & IND's latest numbers.
KREBS BIOCHEMICALS & IND profitability
KREBS BIOCHEMICALS & IND generates a return on equity of 18.4% and a return on capital employed of -30.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of —, KREBS BIOCHEMICALS & IND is conservatively financed. Our overall business-quality score for the company is 3.7 / 10.
Understand the ratios
More on KREBS BIOCHEMICALS & IND
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.